John Overdeck’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
John Overdeck's VRTX Position: Q2 2026 in Review
John Overdeck reduced its Vertex Pharmaceuticals (VRTX) stake by 25% in Q2 2026, selling an estimated $41.3M and leaving 285,000 shares worth $142M. The position accounts for 0.1% of the portfolio, ranked #219.
John Overdeck first reported a position in VRTX in Q2 2015 and has held it in 35 quarters since. The position peaked at $174M in Q3 2021. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- John Overdeck held 285,000 shares of Vertex Pharmaceuticals worth $142M as of Q2 2026.
- John Overdeck sold 93,146 Vertex Pharmaceuticals shares in Q2 2026, an estimated $41.3M.
- Vertex Pharmaceuticals made up 0.1% of John Overdeck's portfolio in Q2 2026, its #219 holding.
- John Overdeck first reported a position in Vertex Pharmaceuticals in Q2 2015 and has held it in 35 quarters since.
- John Overdeck's Vertex Pharmaceuticals position peaked at $174M in Q3 2021.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.